At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 137 enrolled
Drug / intervention
2% Lidocaine jelly +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Double Blinded Randomized Trial Between Lidocaine Jelly And Plain Aqueous Gel For Urethral Straight Catheterization And The Q-Tip Test
In Brief
A Phase 4 clinical trial evaluating 2% Lidocaine jelly and Plain aqueous gel for Pain. Completed, enrolled 137 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
Primary CompletionSep 2008
First PostedApr 2009
TodayJul 2026
First PostedApr 17, 2009
Enrollment StartNov 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.2 years ago
Interventions
2% Lidocaine jellydrug
2% Lidocaine jelly will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.
Plain aqueous geldrug
Plain aqueous gel will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.